ENAGenomicsSTANFORD UNIVERSITYhttps://www.ebi.ac.uk/ena/browser/view/PRJNA1222003Homo sapiensSU2C-SARC032 was a phase II international, randomized trial for patients with localized, high-risk undifferentiated pleomorphic sarcoma or dedifferentiated or pleomorphic liposarcoma of the extremity and limb girdle. On the trial, the addition of perioperative pembrolizumab to preoperative radiotherapy and surgery improved disease-free survival compared to preoperative radiotherapy and surgery alone. Bulk RNA-sequencing was performed on pre-treatment and surgically resected tumor specimens.ENAfalseNon-invasive characterization of human soft tissue sarcoma response to radiation therapyNon-invasive characterization of human soft tissue sarcoma response to radiation therapy2025-09-242025-09-08PRJNA12220039606